about
Structural variability of the ubiquitin specific protease DUSP-UBL double domainsAb initio protein modelling reveals novel human MIT domainsThe MIT domain of UBPY constitutes a CHMP binding and endosomal localization signal required for efficient epidermal growth factor receptor degradationSystematic survey of deubiquitinase localization identifies USP21 as a regulator of centrosome- and microtubule-associated functionsRegulation of ErbB2 receptor status by the proteasomal DUB POH1.mRNA stability in the nucleus.Neuroleukin/Autocrine Motility Factor Receptor Pathway Promotes Proliferation of Articular Chondrocytes through Activation of AKT and Smad2/3.CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.Microfluidics‑based optimization of neuroleukin‑mediated regulation of articular chondrocyte proliferationSelective protein degradation in cell signalling.Governance of endocytic trafficking and signaling by reversible ubiquitylation.Deubiquitylases from genes to organism.The deubiquitylase Ataxin-3 restricts PTEN transcription in lung cancer cells.Direct and indirect control of mitogen-activated protein kinase pathway-associated components, BRAP/IMP E3 ubiquitin ligase and CRAF/RAF1 kinase, by the deubiquitylating enzyme USP15.Characterisation of a GroEL single-ring mutant that supports growth of Escherichia coli and has GroES-dependent ATPase activity.Characterisation of mutations in GroES that allow GroEL to function as a single ring.The USP7 Inhibitor P5091 Induces Cell Death in Ovarian Cancers with Different P53 Status.HRS-WASH axis governs actin-mediated endosomal recycling and cell invasion.Modulation of alternative splicing induced by paclitaxel in human lung cancer.Regulation of Endocytic Trafficking and Signalling by Deubiquitylating EnzymesApigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effectsThe Roles of GroES as a Co-Chaperone for GroELCholesterol content in cell membrane maintains surface levels of ErbB2 and confers a therapeutic vulnerability in ErbB2-positive breast cancerThe exon 19-deleted EGFR undergoes ubiquitylation-mediated endocytic degradation via dynamin activity-dependent and -independent mechanismsThe deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer
P50
Q24293418-C664E76C-7A36-4339-A926-CE090D7D3171Q24322870-215808C5-A368-41B3-9E49-79D4F94ED1FCQ24337922-BEADAD55-C970-4496-9025-A00691B0F9CFQ28575853-2A7A5562-8FAD-44EF-93CF-70595BBF1F5EQ33444766-18B95CE8-56CB-429E-82A7-41449D933716Q33826916-472FE31D-1A28-4378-B3A1-D6D660BCE898Q36150005-DAC6562C-7EDF-42D5-8B1C-45A1D0A278FDQ36356324-916EFBB4-F203-4CEB-A4FA-C21E7D39CB36Q36390160-503AB46A-FCA3-454A-9D8F-B5EFE37258FEQ37985359-8742358C-6DE7-4A00-A889-F6A156DD03E4Q38043227-FCB168F5-55BA-44F7-B9A7-2116064386C9Q38125278-831E7254-1AC0-4294-A23C-76D022B6EBA0Q39051595-DDCDEFDD-805B-412E-AE5C-0D8D2C1D9AD7Q39252412-862202ED-9611-4429-AF7E-C5A31BA22025Q43223705-66F9546D-BE58-4DE6-8050-209288F61952Q44443420-3054B2A8-8CB5-40F3-85FC-A0AA6F5D463BQ47628386-98F749A1-77F2-47EA-82AE-765635D8434BQ54976499-B36B53C3-D527-48AA-9CCF-627C6DC035A6Q55036943-CA07A664-5315-42BF-BA6D-FB0E33E6B961Q57979968-72E0589F-356D-4127-9399-DBF967CA94E7Q58104267-B145D85E-3CDC-4050-85C9-3824AD2ECCD2Q63363475-37B1F231-D7C4-42AA-9DF9-CF040A7512D7Q64264640-A978735E-13B6-4C24-98D3-2C8923EF2D2DQ89432234-346F8030-EEE0-48FB-9A82-DC4512C67E68Q93196147-D98ED15C-7367-4BAB-AEFE-2394C8F34A88
P50
description
Physiologist, researcher
@en
հետազոտող
@hy
name
Han Liu
@ast
Han Liu
@en
Han Liu
@es
Han Liu
@nl
Han Liu
@sl
type
label
Han Liu
@ast
Han Liu
@en
Han Liu
@es
Han Liu
@nl
Han Liu
@sl
prefLabel
Han Liu
@ast
Han Liu
@en
Han Liu
@es
Han Liu
@nl
Han Liu
@sl
P214
P106
P214
P31
P496
0000-0002-0014-4675
P7859
lccn-n2010002130